CAMBRIDGE: EDX Medical Group plc has secured up to £4 million in funding to advance its portfolio of digital diagnostic products and services, the company announced Monday. The financing includes £2 million raised through the issue of 14,285,713 new ordinary shares at 14p per share, and a further £2 million via a convertible loan note…
DUBLIN: Irish biotechnology start-up Aerska has secured $21 million (€18 million) in seed funding to accelerate the development of RNA-based therapies targeting degenerative neurological diseases such as Alzheimer’s and Parkinson’s. The funding round was co-led by venture firms Backed VC and Age1, with additional support from Blueyard, Lingotto, Kerna Ventures, Norrsken, and Speedinvest. The investment…
PARIS: Sanofi Ventures has announced an additional $625 million multi-year capital commitment from Sanofi, increasing its total assets under management to over $1.4 billion. This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative biotech and digital health companies that align with Sanofi’s long-term growth ambitions. “This…
PARIS: Clinical-stage biotech Biophytis SA (Euronext Growth: ALBPS) reported significantly reduced losses for 2024 and outlined ambitious clinical plans for obesity and sarcopenia treatments, while flagging a critical funding gap threatening its operations beyond Q3 2025. The company’s net loss shrank to €10.4 million in 2024, down sharply from €17.0 million in 2023, driven by…